Tandem Diabetes Care (TNDM)
(Real Time Quote from BATS)
$35.03 USD
-0.53 (-1.49%)
Updated Apr 26, 2024 02:42 PM ET
4-Sell of 5 4
D Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC5/2/24 |
---|---|
Current Quarter | -0.80 |
EPS Last Quarter | -0.27 |
Last EPS Surprise | -17.39% |
ABR | 1.85 |
Earnings ESP
|
0.63% |
---|---|
Current Year | -1.62 |
Next Year | -1.07 |
EPS (TTM) | -1.58 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 173.06M | 208.06M | 849.04M | 945.88M |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 175.20M | 220.15M | 852.00M | 973.70M |
Low Estimate | 168.06M | 201.90M | 841.15M | 928.10M |
Year ago Sales | 169.38M | 195.92M | 747.72M | 849.04M |
Year over Year Growth Est. | 2.17% | 6.20% | 13.55% | 11.41% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.80 | -0.47 | -1.62 | -1.07 |
# of Estimates | 8 | 6 | 8 | 8 |
Most Recent Consensus | -0.79 | -0.48 | -1.63 | -0.51 |
High Estimate | -0.74 | -0.41 | -1.36 | -0.51 |
Low Estimate | -0.85 | -0.51 | -1.84 | -1.44 |
Year ago EPS | -0.63 | -0.30 | -1.57 | -1.62 |
Year over Year Growth Est. | -26.98% | -56.67% | -3.18% | 34.02% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 2 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.80 | -0.47 | -1.62 | -1.07 |
7 Days Ago | -0.80 | -0.47 | -1.62 | -1.07 |
30 Days Ago | -0.79 | -0.47 | -1.62 | -1.07 |
60 Days Ago | -0.79 | -0.47 | -1.62 | -1.06 |
90 Days Ago | -0.54 | -0.41 | -1.37 | -0.79 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.79 | -0.48 | -1.63 | -0.51 |
Zacks Consensus Estimate | -0.80 | -0.47 | -1.62 | -1.07 |
Earnings ESP | 0.63% | -2.49% | -0.62% | 52.28% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.27 | -0.38 | -0.30 | -0.63 | NA |
Estimate | -0.23 | -0.35 | -0.54 | -0.56 | NA |
Difference | -0.04 | -0.03 | 0.24 | -0.07 | 0.03 |
Surprise | -17.39% | -8.57% | 44.44% | -12.50% | 1.50% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more